Company Buy Out?










No question Phathom is in the block. $300M mc for a drug that sells $900M in Japan annually and is the next OTC nexium. Bayer. Sanofi. Pfizer. Any pharma co with a consumer arm will want Phathom.
 



























Write your reply...